One such agent, SAR442257, is a trispecific TCE that binds CD38 on multiple myeloma cells, CD3 on T cells and CD28, which is expressed on T cells and some multiple myeloma cells (9, 10). The gene discussed is CD28; the disease is plasma cell myeloma.